2019

Wallace TC, Frankenfeld CL, Frei B, Shah AV, Yu CR, van Klinken JW, Adeleke M. 2019. Multivitamin/multimineral supplement use is associated with increased micronutrient intakes and biomarkers and decreased prevalence of inadequacies and deficiencies in middle-aged and older adults in the United States. J Nutr Gerontol Geriatr 38:307–328.

View Abstract

Slavin M, Huilin L, Frankenfeld CL, Cheskin LJ. 2019. What is needed for evidence-based dietary recommendations for migraine: A call to action for nutrition and microbiome research. Headache J Head Face Pain 10:1566–1581; 10.1111/head.13658.

View Abstract

Mavunda K, Jiang X, Ambrose C. The prevalence of diagnosed chronic lung disease in US infants by gestational age: Implications for RSV policy. Celebration of Pediatric Pulmonology and Sleep, Orlando, FL, February 15–17, 2019.

Bylsma L, Reichert H, Gage S, Roy-Chaudhury P, Nordyke R, Fryzek J, Dahl S, Lithgow T, Lawson J. 2019. Clinical outcomes of arteriovenous access in incident hemodialysis patients with Medicare coverage, 2012-2014. Am J Nephrol 49(2):156-164, doi: 10.1159/000495355.

View Abstract

2018

Ambrose C, Jiang X, Mavunda K. The prevalence of diagnosed chronic lung disease in US infants by gestational age: Implications for RSV policy. ID Week, San Francisco, California, October 4, 2018.

Fryzek JP, Bylsma LC, Nordyke RJ, Sorensen HT. Rare disease epidemiology: A Danish population-based program. Poster presented at National Organization for Rare Disorders’ Rare Disease and Orphan Products Breakthrough Summit, Washington, DC, October 2018.

Ruzin A, Pastula ST, Levin-Sparenberg E, Jiang X, Fryzek J, Tovchigrechko A, Lu B, Qi Y, Liu H, Jin H, Yu L, Hackett J, Villafana T, Esser MT. 2018. Characterization of circulating RSV strains among subjects in the OUTSMART-RSV surveillance program during the 2016-17 winter viral season in the United States. PLoS One 13(7):e0200319.

View Abstract

Bylsma LC, Gulbech Ording A, Froslev T, Mehnert F, Fryzek JP, Morales Arias J, Roth A, Sorensen HT, Berentsen S. Occurrence, survival, and thromboembolic risk in cold agglutinin disease: A population-based cohort analysis. Presented at the 23rd Congress of the European Hematology Association, Stockholm, Sweden, June 2018.

Jensen IS, Wu E, Sacks NC, Cyr PL, Chung KC. 2018. Budget impact analysis of using daunarubicin-cytarabine liposome in patients with newly diagnosed therapy-related AML or AML and myelodysplasia-related changes. Am Health Drug Benefits 11(7):380–386. PMID: 30647825.

View Abstract

Beebe-Dimmer JL, Ruterbusch JJ, Bylsma LC, Gillezeau C, Fryzek J, Schultz NM, Flanders SC, Barlev A, Heath E, Quek RGW. 2018. Patterns of bicalutamide use in prostate cancer treatment: A U.S. real-world analysis using the SEER-Medicare database. Adv Ther 35(1):1438-1451.

View Abstract